Pro-opiomelanocortin is a paradigm for post-translational polyprotein processing. A single 267 AA precursor is proteolytically cleaved by prohormone convertases (PC1/3, PC2) into multiple bioactive peptides with distinct and sometimes ANTAGONISTIC functions. Key products include ACTH (stimulates cortisol release from adrenal cortex), alpha-MSH (anorexigenic, increases pigmentation via MC1R), beta-endorphin (orexigenic opiate), and met-enkephalin. Critically, tissue-specific processing produces different peptide combinations: anterior pituitary corticotrophs produce mainly ACTH; hypothalamic neurons produce both alpha-MSH (appetite suppression) and beta-endorphin (appetite stimulation). GO annotations at the gene level conflate functions that are peptide-specific - ideally annotations should use PRO ontology IDs for peptide-specific functions. POMC mutations cause obesity with adrenal insufficiency and red hair (PMID:9620771).
Curated functional classes representing distinct biological activities. These may be splice variants, cleavage products, or other forms with different functions.
POMC_ACTHPRO_0000024969 (residues 138-176) POMC_ALPHA_MSHPRO_0000024970 (residues 138-150) POMC_BETA_ENDORPHINPRO_0000024975 (residues 237-267) POMC_BETA_MSHPRO_0000024974 (residues 217-234) POMC_GAMMA_MSHPRO_0000024967 (residues 77-87) | GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0001664 G protein-coupled receptor binding | IBA GO_REF:0000033 | MARK AS OVER ANNOTATED | Summary: POMC-derived peptides (ACTH, alpha-MSH, beta-MSH, gamma-MSH) are well-established ligands for melanocortin receptors, but GO:0001664 is a generic parent that is less informative than the accepted specific melanocortin receptor binding terms. Reason: The underlying biology is correct, but POMC curation should prefer specific melanocortin receptor binding terms over generic GPCR binding. ACTH binds MC2R and alpha-MSH binds MC1R/MC3R/MC4R/MC5R; the specific accepted terms in this review capture those activities more cleanly. Supporting Evidence: PMID:19743876 Alpha-MSH and ACTH are endogenous nonselective agonists for MC1R, MC3R, MC4R, and MC5R. file:human/POMC/POMC-deep-research-falcon.md **Melanocortin receptor binding vs generic GPCR binding:** Prefer **melanocortin receptor binding** terms, with **MC2R specificity for ACTH** explicitly supported; do not use generic βGPCR bindingβ for POMC gene product as a catch-all. |
| GO:0005179 hormone activity | IEA GO_REF:0000120 | ACCEPT | Summary: POMC gives rise to multiple peptide hormones including ACTH, MSH peptides, and beta-endorphin. Hormone activity is a core function. IEA is consistent with extensive experimental evidence. Reason: This is the defining function of POMC - it is a prohormone that produces multiple bioactive peptide hormones. UniProt classifies it under "Hormone" keywords, and PMID:9620771 demonstrates hormonal functions through mutation phenotypes. Supporting Evidence: PMID:9620771 Sequential cleavage of the precursor protein pre-pro-opiomelanocortin (POMC) generates the melanocortin peptides adrenocorticotrophin (ACTH), melanocyte-stimulating hormones (MSH) alpha, beta and gamma as well as the opioid-receptor ligand beta-endorphin. file:human/POMC/POMC-deep-research-falcon.md **Pro-opiomelanocortin (POMC)** is best curated in GO as a **secreted prohormone precursor** that is sorted to regulated secretory granules and **proteolytically processed in a tissue-specific manner** to yield multiple bioactive peptides (ACTH, Ξ±/Ξ²/Ξ³-MSH, Ξ²-endorphin; enkephalin motifs embedded in the Ξ²-LPH/Ξ²-endorphin region). |
| GO:0005179 hormone activity | ISS GO_REF:0000024 | ACCEPT | Summary: Duplicate annotation with IEA above, ISS inference from orthologs is appropriate. Reason: Hormone activity is conserved across mammals. ISS annotation is appropriate and consistent with experimental evidence. |
| GO:0005179 hormone activity | IMP PMID:9620771 Severe early-onset obesity, adrenal insufficiency and red ha... | ACCEPT | Summary: The Krude et al. 1998 paper describes POMC-null patients with adrenal insufficiency (loss of ACTH hormone function) and obesity (loss of alpha-MSH hormone function). IMP from mutant phenotype is well-justified. Reason: Loss of POMC function results in loss of hormonal activity - ACTH deficiency causes secondary hypocortisolism, alpha-MSH deficiency causes obesity and red hair. This directly demonstrates hormone activity through loss-of-function. Supporting Evidence: PMID:9620771 early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans |
| GO:0005515 protein binding | IPI PMID:32296183 A reference map of the human binary protein interactome. | REMOVE | Summary: High-throughput Y2H interactome study (HuRI) identified POMC interactors. However, 'protein binding' is uninformative for a secreted prohormone. The actual function is GPCR binding, which is separately annotated. Reason: 'Protein binding' is too vague and uninformative for a prohormone. The meaningful interactions are with melanocortin receptors and opioid receptors, which are captured by more specific MF terms. HuRI Y2H interactions for a secreted/processed prohormone are likely not physiologically relevant - POMC is processed in the secretory pathway and its products function extracellularly. Supporting Evidence: PMID:32296183 HuRI is estimated to represent 2β11% of the binary protein interactome file:human/POMC/POMC-deep-research-falcon.md **Generic protein binding / identical protein binding:** Do not annotate generic binding (including βidentical protein bindingβ) unless there is direct biochemical interaction evidence for the relevant molecular entity (precursor vs peptide). |
| GO:0005102 signaling receptor binding | IMP PMID:9620771 Severe early-onset obesity, adrenal insufficiency and red ha... | ACCEPT | Summary: Loss of POMC function causes phenotypes consistent with loss of signaling through melanocortin receptors (MC1R for pigmentation, MC4R for appetite, MC2R for ACTH). This is a valid parent term for the more specific MCR binding terms. Reason: POMC-derived peptides bind melanocortin receptors (signaling receptors). This is correctly inferred from mutant phenotype - loss of receptor activation. More specific terms (MC1R/MC3R/MC4R binding) provide additional detail. Supporting Evidence: PMID:9620771 Recent studies in animal models elucidated a central role of alpha-MSH in the regulation of food intake by activation of the brain melanocortin-4-receptor (MC4-R; refs 3-5) |
| GO:0070996 type 1 melanocortin receptor binding | IPI PMID:19743876 Novel binding motif of ACTH analogues at the melanocortin re... | ACCEPT | Summary: Yang et al. 2009 directly tested ACTH and MSH peptide binding to melanocortin receptors. ACTH and alpha-MSH bind MC1R. This is a core molecular function. Reason: Direct binding studies demonstrate alpha-MSH and ACTH bind MC1R. This receptor mediates pigmentation effects of MSH peptides. MC1R binding is a core function of alpha-MSH (POMC 138-150). Supporting Evidence: PMID:19743876 Alpha-MSH and ACTH are endogenous nonselective agonists for MC1R, MC3R, MC4R, and MC5R. |
| GO:0070996 type 1 melanocortin receptor binding | IDA PMID:18292087 Melanocortin-1 receptor signaling markedly induces the expre... | ACCEPT | Summary: Smith et al. 2008 studied MC1R signaling using alpha-MSH agonists. Confirms MC1R binding by melanocortin peptides. Reason: The study uses MC1R agonist (NDP-alpha-MSH) and wild-type alpha-MSH to study MC1R signaling in melanocytes, confirming MC1R binding as a core function. Supporting Evidence: PMID:18292087 the potent MC1R agonist (Nle4,D-Phe7)-alpha-melanocyte-stimulating hormone |
| GO:0031781 type 3 melanocortin receptor binding | IPI PMID:19743876 Novel binding motif of ACTH analogues at the melanocortin re... | ACCEPT | Summary: Yang et al. 2009 demonstrated ACTH and alpha-MSH binding to MC3R through receptor binding and activation studies. Reason: MC3R is a target of alpha-MSH and ACTH peptides. The paper directly demonstrates receptor binding and activation at hMC3R. Gamma-MSH from POMC preferentially binds MC3R. Supporting Evidence: PMID:19743876 Alpha-MSH and ACTH are endogenous nonselective agonists for MC1R, MC3R, MC4R, and MC5R |
| GO:0031782 type 4 melanocortin receptor binding | IPI PMID:19743876 Novel binding motif of ACTH analogues at the melanocortin re... | ACCEPT | Summary: MC4R binding is critical for appetite regulation by alpha-MSH. This is the key receptor mediating anorexigenic effects of alpha-MSH in hypothalamus. Reason: MC4R binding by alpha-MSH is the molecular basis of POMC's role in appetite suppression. Loss of this interaction explains obesity in POMC-null patients. Core molecular function. Supporting Evidence: PMID:19743876 Alpha-MSH and ACTH are endogenous nonselective agonists for MC1R, MC3R, MC4R, and MC5R PMID:9620771 Recent studies in animal models elucidated a central role of alpha-MSH in the regulation of food intake by activation of the brain melanocortin-4-receptor (MC4-R; refs 3-5) |
| GO:0001664 G protein-coupled receptor binding | IDA PMID:19452503 Aberrant trafficking of human melanocortin 1 receptor varian... | MARK AS OVER ANNOTATED | Summary: Sanchez-Laorden et al. 2009 studied MC1R trafficking and activation, demonstrating melanocortin ligand biology, but the GO annotation uses a generic GPCR binding parent. Reason: The paper supports MC1R pathway biology, but specific melanocortin receptor binding terms are already present and more informative. GO:0001664 should not be retained as a core generic catch-all for POMC-derived peptide receptor binding. Supporting Evidence: PMID:19452503 The melanocortin 1 receptor (MC1R), a Gs protein-coupled receptor (GPCR) expressed in melanocytes file:human/POMC/POMC-deep-research-falcon.md **Melanocortin receptor binding vs generic GPCR binding:** Prefer **melanocortin receptor binding** terms, with **MC2R specificity for ACTH** explicitly supported; do not use generic βGPCR bindingβ for POMC gene product as a catch-all. |
| GO:0005615 extracellular space | IBA GO_REF:0000033 | ACCEPT | Summary: POMC-derived peptides are secreted hormones that function in the extracellular space. IBA phylogenetic inference is appropriate. Reason: All POMC-derived bioactive peptides (ACTH, MSH, beta-endorphin) are secreted and function extracellularly to bind receptors on target cells. UniProt notes "Secreted" for subcellular location. |
| GO:0005576 extracellular region | IEA GO_REF:0000120 | ACCEPT | Summary: Extracellular region is the broader parent term. POMC products are secreted and act extracellularly. Reason: Consistent with secreted hormone function. Appropriate IEA inference. |
| GO:0030141 secretory granule | IBA GO_REF:0000033 | ACCEPT | Summary: POMC is stored in and processed within secretory granules in pituitary and hypothalamic neurons before release. IBA is appropriate. Reason: UniProt notes that alpha-MSH and beta-endorphin are stored in separate granules in hypothalamic POMC neurons. Secretory granule localization is well-established. Supporting Evidence: UniProtKB:P01189 Melanocyte-stimulating hormone alpha and beta-endorphin are stored in separate granules in hypothalamic POMC neurons |
| GO:0005615 extracellular space | IEA GO_REF:0000107 | ACCEPT | Summary: Duplicate of IBA annotation above. Extracellular space is correct for secreted peptide hormones. Reason: IEA inference consistent with experimental evidence for secreted localization. |
| GO:0005737 cytoplasm | IEA GO_REF:0000107 | MARK AS OVER ANNOTATED | Summary: POMC transits through cytoplasm during biosynthesis but this is not its functional location. This is over-annotation. Reason: While POMC precursor passes through the cytoplasm during synthesis, this is not meaningful for function. POMC enters the secretory pathway via signal peptide and is processed in ER/Golgi/secretory granules. Cytoplasm annotation is technically true but functionally misleading. |
| GO:0030141 secretory granule | IEA GO_REF:0000107 | ACCEPT | Summary: Duplicate of IBA annotation. Secretory granule localization is correct. Reason: IEA inference consistent with IBA and experimental evidence. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-379044 | ACCEPT | Summary: Reactome pathway annotation for GPCR signaling. Extracellular region is where ligands interact with receptors. Reason: Appropriate localization for secreted hormone peptides. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-388596 | ACCEPT | Summary: Reactome annotation for melanocortin receptor binding. Multiple Reactome TAS annotations to same GO term represent different pathway contexts. Reason: Valid annotation - POMC peptides bind melanocortin receptors extracellularly. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-744886 | ACCEPT | Summary: Reactome annotation for GPCR:Gs complex dissociation pathway. Reason: Valid - ligands act extracellularly to activate GPCRs. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-744887 | ACCEPT | Summary: Reactome annotation for liganded Gs-activating GPCRs. Reason: Valid - melanocortins bind Gs-coupled MCRs extracellularly. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-5603251 | ACCEPT | Summary: Reactome annotation for defective ACTH not binding MC2R. Reason: Valid pathway annotation - ACTH acts extracellularly on MC2R. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-112042 | ACCEPT | Summary: Reactome annotation for opioid binding to MOR (mu opioid receptor). Beta-endorphin is the POMC product that binds opioid receptors. Reason: Beta-endorphin (POMC 237-267) binds mu-opioid receptor extracellularly. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-112271 | ACCEPT | Summary: Reactome annotation for receptor:G-protein complex dissociation in opioid signaling. Reason: Valid pathway annotation for beta-endorphin function. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-167408 | ACCEPT | Summary: Reactome annotation for high affinity receptor:G-protein binding. Reason: Valid - POMC peptides act as extracellular ligands for GPCRs. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-167419 | ACCEPT | Summary: Reactome annotation for GDP release from receptor:G-protein complex. Reason: Valid pathway annotation. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-167427 | ACCEPT | Summary: Reactome annotation for opioid dissociation from MOR. Reason: Valid - beta-endorphin binds MOR extracellularly. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-167429 | ACCEPT | Summary: Reactome annotation for GTP binding to receptor:G-protein complex. Reason: Valid pathway annotation. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-374298 | ACCEPT | Summary: Reactome annotation for opioid receptors binding opioid peptides. Reason: Beta-endorphin and met-enkephalin from POMC bind opioid receptors extracellularly. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-380073 | ACCEPT | Summary: Reactome annotation for Gi-coupled GPCR activation (opioid signaling). Reason: Valid - opioid receptors are Gi-coupled, beta-endorphin acts extracellularly. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-388605 | ACCEPT | Summary: Reactome annotation specifically for ACTH (POMC 138-176) binding MC2R. Reason: Core function - ACTH binds MC2R extracellularly to stimulate cortisol release. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-6789615 | ACCEPT | Summary: Reactome annotation for STAT3-upregulated extracellular proteins. Reason: Valid - POMC products are extracellular. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-749454 | ACCEPT | Summary: Reactome annotation for Gi complex dissociation. Reason: Valid pathway annotation for opioid signaling. |
| GO:0005576 extracellular region | TAS Reactome:R-HSA-749456 | ACCEPT | Summary: Reactome annotation for Gi-coupled GPCR binding. Reason: Valid - opioid peptides act extracellularly. |
| GO:0034774 secretory granule lumen | TAS Reactome:R-HSA-265301 | ACCEPT | Summary: Reactome annotation for corticotropin cleavage from POMC. Processing occurs in secretory granule lumen. Reason: POMC processing by prohormone convertases (PC1/3, PC2) occurs in the lumen of secretory granules. This is where the mature peptides are generated. |
| GO:0005782 peroxisomal matrix | IDA PMID:20810565 Peroxisomal localization of the proopiomelanocortin-derived ... | KEEP AS NON CORE | Summary: Hoftberger et al. 2010 report surprising peroxisomal localization of beta-LPH and beta-endorphin in cells expressing ALDP. This is tissue-specific and applies only to the C-terminal POMC products. Reason: The paper demonstrates peroxisomal localization specifically for beta-LPH and beta-endorphin (C-terminal POMC products) in cells expressing ALDP. However, N-terminal peptides (ACTH, alpha-MSH, gamma-MSH) were NOT found in peroxisomes. This is a specialized localization, not a core function. Supporting Evidence: PMID:20810565 In contrast to the peptide hormones Ξ²-LPH and Ξ²-endorphin, which are derived from the C terminus of POMC, the N-terminal peptides ACTH, Ξ±-MSH, and Ξ³-MSH were never detected in peroxisomes. |
| GO:0005615 extracellular space | IDA PMID:9620771 Severe early-onset obesity, adrenal insufficiency and red ha... | ACCEPT | Summary: The Krude paper describes POMC mutation phenotypes but does not directly demonstrate extracellular localization. However, the inferred hormonal function implies extracellular action. Reason: While not directly demonstrated in this paper, POMC products function as circulating hormones, which by definition are extracellular. Supporting Evidence: PMID:9620771 Sequential cleavage of the precursor protein pre-pro-opiomelanocortin (POMC) generates the melanocortin peptides adrenocorticotrophin (ACTH), melanocyte-stimulating hormones (MSH) alpha, beta and gamma as well as the opioid-receptor ligand beta-endorphin |
| GO:0005737 cytoplasm | ISS GO_REF:0000024 | MARK AS OVER ANNOTATED | Summary: ISS annotation for cytoplasm. Like the IEA annotation, this is technically true but functionally misleading. Reason: Cytoplasm is not a meaningful functional location for POMC. The protein enters the secretory pathway and functions extracellularly. |
| GO:0030141 secretory granule | ISS GO_REF:0000024 | ACCEPT | Summary: ISS annotation consistent with IBA and IEA annotations. Secretory granule is a valid localization. Reason: Secretory granule storage and processing is conserved across POMC orthologs. |
| GO:2000852 regulation of corticosterone secretion | IBA GO_REF:0000033 | ACCEPT | Summary: ACTH (POMC 138-176) stimulates adrenal cortex to release glucocorticoids. In rodents, this is corticosterone; in humans, cortisol. IBA annotation is appropriate for the conserved function. Reason: ACTH regulation of adrenal glucocorticoid secretion is the primary function of the HPA axis. This is conserved across mammals - the specific glucocorticoid varies but the mechanism is the same. Supporting Evidence: PMID:9620771 While a few cases of isolated ACTH deficiency have been reported (OMIM 201400), an inherited POMC defect has not been described so far. |
| GO:0007218 neuropeptide signaling pathway | IEA GO_REF:0000043 | ACCEPT | Summary: POMC produces multiple neuropeptides (alpha-MSH, beta-endorphin) that function in hypothalamic signaling. UniProt keyword mapping is appropriate. Reason: Alpha-MSH and beta-endorphin are classical neuropeptides produced in hypothalamic POMC neurons. Neuropeptide signaling is a core function. |
| GO:0106071 positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway | IEA GO_REF:0000107 | ACCEPT | Summary: Melanocortin receptors (MC1R-MC5R) are Gs-coupled GPCRs that activate adenylate cyclase. POMC peptides as ligands positively regulate this pathway. Reason: MC1R, MC2R, MC3R, MC4R, and MC5R are all coupled to Gs and activate adenylate cyclase upon binding melanocortin peptides. This is the signaling mechanism. |
| GO:0140668 positive regulation of oxytocin production | IEA GO_REF:0000107 | MARK AS OVER ANNOTATED | Summary: Some evidence suggests melanocortins affect oxytocin release, but this is not a well-established core function of POMC. Reason: While there may be some regulatory effects of melanocortins on oxytocin, this is not a direct or primary function of POMC. The evidence base is limited and this appears to be an over-extension of IEA transfer. |
| GO:1990680 response to melanocyte-stimulating hormone | IEA GO_REF:0000107 | REMOVE | Summary: This annotation is problematic - POMC PRODUCES melanocyte-stimulating hormone, it does not respond to it. This appears to be an erroneous annotation. Reason: POMC is the precursor that produces MSH peptides. It does not respond to MSH. This annotation appears to confuse POMC with MSH receptors or downstream targets. POMC-expressing cells may respond to feedback, but the gene product itself does not "respond to MSH." |
| GO:0106071 positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway | ISS GO_REF:0000024 | ACCEPT | Summary: Duplicate of IEA annotation. ISS is appropriate as melanocortin receptor signaling mechanism is conserved. Reason: Conserved function - melanocortin receptors couple to Gs and activate AC. |
| GO:0019722 calcium-mediated signaling | ISS GO_REF:0000024 | KEEP AS NON CORE | Summary: Some melanocortin receptors can couple to calcium signaling, but this is not the primary signaling mechanism for most MCRs. Reason: While MC1R and other MCRs can activate calcium signaling in some contexts, the primary signaling mechanism is cAMP/PKA via Gs coupling. Calcium signaling is a secondary effect, not a core function. |
| GO:1990680 response to melanocyte-stimulating hormone | ISS GO_REF:0000024 | REMOVE | Summary: Same issue as IEA annotation - POMC produces MSH, it does not respond to it. Reason: POMC is the source of MSH, not a responder. This annotation is erroneous. |
| GO:0006091 generation of precursor metabolites and energy | IMP PMID:9620771 Severe early-onset obesity, adrenal insufficiency and red ha... | MARK AS OVER ANNOTATED | Summary: POMC-null patients have metabolic abnormalities, but this is an indirect effect of hormone loss, not a direct molecular function. This term is too general. Reason: While POMC loss affects metabolism (obesity, adrenal insufficiency), this is an indirect consequence of loss of hormonal regulation, not a direct role in energy generation pathways. This annotation is over-interpretation of phenotype data. Supporting Evidence: PMID:9620771 early-onset obesity, adrenal insufficiency and red hair pigmentation |
| GO:0007165 signal transduction | IMP PMID:9620771 Severe early-onset obesity, adrenal insufficiency and red ha... | ACCEPT | Summary: POMC-derived peptides are signaling molecules that activate receptor signaling. This is correct but very general. Reason: All POMC peptide hormones function by activating signal transduction cascades through their receptors. This is a valid high-level annotation. Supporting Evidence: PMID:9620771 Recent studies in animal models elucidated a central role of alpha-MSH in the regulation of food intake by activation of the brain melanocortin-4-receptor (MC4-R; refs 3-5) and the linkage of human obesity to chromosome 2 in close proximity to the POMC locus, led to the proposal of an association of POMC with human obesity |
| GO:0007267 cell-cell signaling | IMP PMID:9620771 Severe early-onset obesity, adrenal insufficiency and red ha... | ACCEPT | Summary: POMC-derived peptides mediate cell-cell signaling between endocrine cells and target tissues. This is a core function. Reason: ACTH signals from pituitary to adrenal cortex, alpha-MSH signals between hypothalamic neurons and melanocytes/hypothalamic circuits. Classical cell-cell signaling function. Supporting Evidence: PMID:9620771 Sequential cleavage of the precursor protein pre-pro-opiomelanocortin (POMC) generates the melanocortin peptides adrenocorticotrophin (ACTH), melanocyte-stimulating hormones (MSH) alpha, beta and gamma as well as the opioid-receptor ligand beta-endorphin |
| GO:0008217 regulation of blood pressure | ISS GO_REF:0000024 | KEEP AS NON CORE | Summary: ACTH affects blood pressure through cortisol release; alpha-MSH may have direct cardiovascular effects via MC3R/MC4R. However, this is not a primary function of POMC. Reason: Blood pressure regulation is an indirect effect of POMC peptides, primarily through ACTH-stimulated glucocorticoid release. Not a core direct function. |
| GO:0032098 regulation of appetite | IMP PMID:9620771 Severe early-onset obesity, adrenal insufficiency and red ha... | MODIFY | Summary: POMC-null patients have severe obesity due to hyperphagia, demonstrating POMC role in appetite regulation. HOWEVER, this annotation conflates antagonistic functions: alpha-MSH suppresses appetite (anorexigenic) while beta-endorphin stimulates appetite (orexigenic). Reason: The term "regulation of appetite" is appropriate at the gene level because POMC produces BOTH appetite-suppressing (alpha-MSH via MC4R) AND appetite- stimulating (beta-endorphin via opioid receptors) peptides. The net effect in POMC-null patients is obesity because alpha-MSH loss predominates. However, ideally this should be annotated at the peptide level with specific terms (GO:0032099 negative regulation of appetite for alpha-MSH; GO:0032100 positive regulation of appetite for beta-endorphin). Proposed replacements: negative regulation of appetite positive regulation of appetite Supporting Evidence: PMID:9620771 alpha-MSH in the regulation of food intake by activation of the brain melanocortin-4-receptor UniProtKB:P01189 -!- FUNCTION: [Beta-endorphin]: Endogenous orexigenic opiate. file:human/POMC/POMC-deep-research-falcon.md Appetite and stress are supported mechanistically through defined endocrine/neuropeptide pathways (Ξ±-MSH β MC3R/MC4R; ACTH β MC2R). Prefer pathway-grounded BP terms (e.g., regulation of food intake; regulation of glucocorticoid secretion) over very broad behavior/development annotations. |
| GO:0033059 cellular pigmentation | IMP PMID:9620771 Severe early-onset obesity, adrenal insufficiency and red ha... | ACCEPT | Summary: POMC-null patients have red hair and fair skin, demonstrating alpha-MSH role in pigmentation via MC1R. This is a core function of alpha-MSH. Reason: Alpha-MSH binding to MC1R in melanocytes stimulates melanin production. Loss of alpha-MSH (POMC mutation) causes red hair/fair skin phenotype. Core function. Supporting Evidence: PMID:9620771 red hair pigmentation caused by POMC mutations UniProtKB:P01189 [Melanocyte-stimulating hormone alpha]: Increases the pigmentation of skin by increasing melanin production in melanocytes. |
| GO:0032720 negative regulation of tumor necrosis factor production | IDA PMID:10233018 alpha-MSH and its receptors in regulation of tumor necrosis ... | KEEP AS NON CORE | Summary: Taherzadeh et al. 1999 demonstrated alpha-MSH inhibits TNF-alpha production in macrophages. This is an anti-inflammatory function of alpha-MSH. Reason: The paper demonstrates alpha-MSH suppresses TNF-alpha in LPS-stimulated macrophages via MC1R. This is a validated function but represents the immunomodulatory role of alpha-MSH, which is secondary to its pigmentation and appetite regulation functions. Supporting Evidence: PMID:10233018 The inflammatory cytokine tumor necrosis factor (TNF)-alpha was inhibited in relation to alpha-MSH concentration. |
| GO:0045944 positive regulation of transcription by RNA polymerase II | IDA PMID:18292087 Melanocortin-1 receptor signaling markedly induces the expre... | MARK AS OVER ANNOTATED | Summary: Smith et al. 2008 showed MC1R signaling (via alpha-MSH) induces transcription of NR4A nuclear receptors in melanocytes. This is downstream of receptor activation, not a direct function of POMC. Reason: This annotation conflates ligand function with downstream transcriptional effects. Alpha-MSH binding to MC1R activates cAMP/PKA which then activates transcription factors. POMC peptides do not directly regulate transcription; they bind extracellular receptors. This is over-annotation. Supporting Evidence: PMID:18292087 Here we show that MC1R signaling in B16 mouse melanoma cells and primary human melanocytes rapidly, and transiently, induces the transcription of the NR4A subfamily of orphan nuclear receptors |
| GO:0016486 peptide hormone processing | NAS | NEW | Summary: Added to align core_functions with existing annotations. Reason: Core function term not present in existing_annotations. Supporting Evidence: PMID:9620771 Sequential cleavage of the precursor protein pre-pro-opiomelanocortin (POMC) generates the melanocortin peptides adrenocorticotrophin (ACTH), melanocyte-stimulating hormones (MSH) alpha, beta and gamma as well as the opioid-receptor ligand beta-endorphin. UniProtKB:P01189 Specific enzymatic cleavages at paired basic residues yield the different active peptides. file:human/POMC/POMC-deep-research-falcon.md Canonical regulated-secretory-pathway processing of POMC uses **PCSK1/PC1-3** and **PCSK2/PC2** endoproteolysis, followed by exopeptidase trimming (e.g., **CPE**) and additional modifications that can alter activity (e.g., acetylation affecting Ξ²-endorphin opioid activity). |
| GO:0031780 corticotropin hormone receptor binding | NAS | NEW | Summary: Added to align core_functions with existing annotations. Reason: Core function term not present in existing_annotations. Supporting Evidence: PMID:9620771 While a few cases of isolated ACTH deficiency have been reported (OMIM 201400), an inherited POMC defect has not been described so far. Reactome:R-HSA-388605 POMC(138-176) binds MC2R file:human/POMC/POMC-deep-research-falcon.md **MC2R (ACTH receptor) is uniquely selective**: MC2R binds a **single endogenous ligand, ACTH**βimportant for GO term choice (**melanocortin receptor binding** rather than generic GPCR binding). |
| GO:2000851 positive regulation of glucocorticoid secretion | NAS | NEW | Summary: Added to align core_functions with existing annotations. Reason: Core function term not present in existing_annotations. Supporting Evidence: Reactome:R-HSA-388605 POMC(138-176) binds MC2R |
| GO:0051464 positive regulation of cortisol secretion | NAS | NEW | Summary: Added to align core_functions with existing annotations. Reason: Core function term not present in existing_annotations. Supporting Evidence: PMID:9620771 early-onset obesity, adrenal insufficiency and red hair pigmentation Reactome:R-HSA-388605 POMC(138-176) binds MC2R |
| GO:0097009 energy homeostasis | NAS | NEW | Summary: Added to align core_functions with existing annotations. Reason: Core function term not present in existing_annotations. Supporting Evidence: PMID:9620771 Recent studies in animal models elucidated a central role of alpha-MSH in the regulation of food intake by activation of the brain melanocortin-4-receptor (MC4-R; refs 3-5) PMID:19743876 Alpha-MSH and ACTH are endogenous nonselective agonists for MC1R, MC3R, MC4R, and MC5R. |
| GO:0042438 melanin biosynthetic process | NAS | NEW | Summary: Added to align core_functions with existing annotations. Reason: Core function term not present in existing_annotations. Supporting Evidence: PMID:9620771 red hair pigmentation caused by POMC mutations UniProtKB:P01189 [Melanocyte-stimulating hormone alpha]: Increases the pigmentation of skin by increasing melanin production in melanocytes. PMID:18292087 MC1R signaling in B16 mouse melanoma cells and primary human melanocytes |
| GO:0001515 opioid peptide activity | NAS | NEW | Summary: Added to align core_functions with existing annotations. Reason: Core function term not present in existing_annotations. Supporting Evidence: UniProtKB:P01189 -!- FUNCTION: [Beta-endorphin]: Endogenous orexigenic opiate. Reactome:R-HSA-374298 Opioid receptors bind opioid peptides file:human/POMC/POMC-deep-research-falcon.md Ξ²-endorphin is described as a POMC-derived peptide that binds opioid receptors (ΞΌ/Ξ΄/ΞΊ) with agonist activity for major forms. |
| GO:0051930 regulation of sensory perception of pain | NAS | NEW | Summary: Added to align core_functions with existing annotations. Reason: Core function term not present in existing_annotations. Supporting Evidence: UniProtKB:P01189 -!- FUNCTION: [Beta-endorphin]: Endogenous orexigenic opiate. Reactome:R-HSA-374298 Opioid receptors bind opioid peptides |
Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)